InDaily InDaily

Support independent Journalism Donate Subscribe
Support independent journalism

drug

Business Business

Mayne Pharma shares rise over US deal

Mayne Pharma shares have soared 19 per cent to a near five-month high, after the Adelaide-based pharmaceutical company inked an exclusive long-term deal to sell a new contraceptive drug in the United States.

Get InDaily in your inbox. Daily. The best local news sent straight to your inbox every workday at lunchtime.

Thanks for signing up to the InDaily newsletter.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.